HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation.
Metabolic bioactivation of polycyclic aromatic hydrocarbons, such as the environmental procarcinogen benzo[a]pyrene, is catalyzed by a cytochrome P450 monooxygenase encoded by the substrate-inducible Cyp1a1 gene. Cyp1a1 induction requires trans-activation by the heterodimeric transcriptional complex formed by the liganded Ah receptor (AHR) and its partner, ARNT. Previously, we showed that constitutively bound HDAC1 dissociates from Cyp1a1 promoter chromatin after ligand-mediated induction, concomitantly with the recruitment of AHR/ARNT complexes and p300. Here, we investigated the hypothesis that HDAC1 binding maintains the Cyp1a1 gene in a silenced state in uninduced cells. We find that Cyp1a1 induction by the AHR/ARNT is associated with modification of specific chromatin marks, including hyperacetylation of histone H3K14 and H4K16, trimethylation of histone H3K4, and phosphorylation of H3S10. HDAC1 and DNMT1 form complexes on the Cyp1a1 promoter of uninduced cells but HDAC1 inhibition alone is not sufficient to induce Cyp1a1 expression, although it allows for the hyperacetylation of H3K14 and H4K16 to levels similar to those found in B[a]P-induced cells. These results show that by blocking the modification of histone marks, HDAC1 plays a central role in Cyp1a1 expression and that its removal is a necessary but not sufficient condition for Cyp1a1 induction, underscoring the requirement for a concerted series of chromatin-remodeling events to complete the initial steps of gene trans-activation by the Ah receptor.
Schnekenburger
Michael
M
Center for Environmental Genetics and Department of Environmental Health, University of Cincinnati Medical Center, P.O. Box 670056, Cincinnati, Ohio 45267-0056, USA.
Peng
Li
L
Puga
Alvaro
A
D000107:Acetylation; D000818:Animals; D001564:Benzo(a)pyrene / Q000378:metabolism; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D002384:Catalysis; D045744:Cell Line, Tumor; D042002:Chromatin Assembly and Disassembly / Q000502:physiology; D019363:Cytochrome P-450 CYP1A1 / Q000096:biosynthesis*; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000378:metabolism; D004790:Enzyme Induction / Q000502:physiology; D004794:Enzyme Repression / Q000502:physiology; D005326:Fetal Proteins / Q000235:genetics / Q000378:metabolism; D056284:Histone Deacetylase 1; D006655:Histone Deacetylases / Q000378:metabolism*; D006657:Histones / Q000378:metabolism*; D008745:Methylation; D051379:Mice; D008869:Microtubule-Associated Proteins; D010766:Phosphorylation; D011401:Promoter Regions, Genetic / Q000502:physiology*; D011485:Protein Binding / Q000502:physiology; D011499:Protein Processing, Post-Translational / Q000502:physiology; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism*; D015533:Transcriptional Activation / Q000502:physiology*; D050880:p300-CBP Transcription Factors
D002352:Carrier Proteins; D005326:Fetal Proteins; D006657:Histones; D008869:Microtubule-Associated Proteins; D018336:Receptors, Aryl Hydrocarbon; C418485:TACC3 protein, mouse; D001564:Benzo(a)pyrene; D019363:Cytochrome P-450 CYP1A1; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; C000619381:Dnmt1 protein, mouse; D050880:p300-CBP Transcription Factors; C484389:Hdac1 protein, mouse; D056284:Histone Deacetylase 1; D006655:Histone Deacetylases
Mol Cell Biol. 2001 Apr;21(7):2594-607
11259606
Nature. 2005 Aug 25;436(7054):1103-6
16121170
Carcinogenesis. 2001 Jul;22(7):1077-86
11408352
Mol Cell Biol. 2002 Mar;22(6):1844-57
11865062
J Biol Chem. 2002 Apr 5;277(14):11821-7
11805098
Mol Cell Biol. 2002 Jun;22(12):4319-33
12024042
Methods. 2002 Jan;26(1):48-56
12054904
Mol Cell Biol. 2003 Nov;23(21):7920-5
14560034
J Biol Chem. 2003 Nov 7;278(45):44041-8
12917420
N Engl J Med. 2003 Nov 20;349(21):2042-54
14627790
Cancer Sci. 2004 Jan;95(1):1-6
14720319
J Biol Chem. 2004 Feb 6;279(6):4110-9
14625279
J Cell Biochem. 2004 Sep 1;93(1):57-67
15352162
Annu Rev Pharmacol Toxicol. 1982;22:517-54
6282188
Cancer Res. 1982 Dec;42(12):4875-917
6814745
Mol Cell Biol. 1989 Jun;9(6):2378-86
2548080
Cell. 2005 Sep 9;122(5):654-8
16143099
Eur J Cancer. 2005 Nov;41(16):2381-402
16226460
Science. 2006 Feb 10;311(5762):844-7
16469925
Cancer Res. 2006 Apr 1;66(7):3541-9
16585178
Cell. 2006 Apr 21;125(2):315-26
16630819
J Biol Chem. 2006 May 26;281(21):14654-62
16567799
J Immunol. 2006 Jul 15;177(2):1282-8
16818788
Cancer Res. 2006 Aug 1;66(15):7420-8
16885337
Cancer Biol Ther. 2007 Jan;6(1):64-9
17172825
Genes Dev. 2000 Jan 1;14(1):45-54
10640275
J Biol Chem. 2000 Mar 24;275(12):8432-8
10722677
Nat Genet. 2000 Jul;25(3):338-42
10888886
Genes Dev. 2000 Jul 15;14(14):1810-23
10898795
Cell. 2000 Oct 13;103(2):263-71
11057899
J Biol Chem. 1989 Oct 25;264(30):17754-8
2553691
Crit Rev Toxicol. 1989;20(3):153-74
2558673
Mol Cell Biol. 1990 Apr;10(4):1470-5
2320004
Mol Cell Biol. 1990 Oct;10(10):5098-105
2398886
Mol Cell Biol. 1992 Apr;12(4):1856-63
1312672
J Biol Chem. 1992 Apr 5;267(10):6874-8
1313025
Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11622-6
1454854
Annu Rev Pharmacol Toxicol. 1995;35:307-40
7598497
Mol Cell Biol. 1996 Jan;16(1):430-6
8524325
Biochem Pharmacol. 1997 Apr 4;53(7):951-7
9174108
J Biochem. 1997 Oct;122(4):703-10
9399571
J Biol Chem. 1998 Jan 30;273(5):2895-904
9446600
Arch Biochem Biophys. 1999 Jul 15;367(2):250-7
10395741
J Biol Chem. 1999 Aug 6;274(32):22155-64
10428779
J Biol Chem. 1999 Oct 1;274(40):28708-15
10497241
Annu Rev Genet. 2004;38:413-43
15568982
J Biol Chem. 2005 Jan 28;280(4):2446-54
15537652
Annu Rev Biochem. 2005;74:481-514
15952895
J Cell Biol. 2001 Feb 19;152(4):669-82
11266459